Phospholipid Flip-flop in Biogenic Membranes

生物膜中的磷脂触发器

基本信息

  • 批准号:
    7255834
  • 负责人:
  • 金额:
    $ 30.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-07-01 至 2009-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long-term objective of this proposal is to elucidate the mechanism(s) by which polar lipids are flip-flopped across biogenic (self-synthesizing) membranes such as the endoplasmic reticulum (ER). This is an important, unresolved question in membrane biology. Discovering the molecular basis of flipping is essential to understanding how the phospholipid bilayer of biomembranes is propagated, and how the topologically complex syntheses of various glycolipids are executed. The latter processes are required for assembling biologically important cell surface molecules such as N-glycosylated and glycosylphosphatidylinositol (GPI)-anchored proteins in eukaryotes, and O-antigen-modified lipopolysaccharide in Gram-negative bacteria. (Glyco)phospholipid flip-flop does not occur at an appreciable rate in protein-free liposomes but occurs rapidly in the ER via a protein-dependent, metabolic energy-independent, bi-directional, facilitated diffusion process. We hypothesize that specific proteins, biogenic membrane flippases, facilitate the transbilayer diffusion of polar lipids in the ER, including the glycerophospholipids and isoprenoid-based glycolipids that are the focus of this proposal. The characteristics of lipid flip-flop in the ER rule out the participation of ABC transporters that have been identified as potential lipid translocators in other membrane settings. No biogenic membrane flippases have been identified that flip glycerophospholipids and isoprenoid-P-sugars, but compelling genetic evidence points to a membrane protein, Rft1p, as a flippase for dolichol-pyrophosphate based glycolipids in the ER-localized pathway of protein , N-glycosylation. We propose 2 specific aims: to characterize and identify a glycerophospholipid flippase from yeast and rat liver ER and to test biochemically the role of yeast Rft1p in flipping dolichol-PP-based glycolipids. These studies will make use of procedures that we have developed for the functional reconstitution and assay of lipid flip-flop in proteoliposomes generated from a detergent-extract of ER. We anticipate that our results will define a new class of membrane proteins for which no clear prototype currently exists and begin to address our eventual goal of obtaining a molecular definition of the mechanism of lipid flip-flop in biogenic membranes.
描述(由申请人提供):本提案的长期目标是阐明极性脂质在生物(自合成)膜(如内质网(ER))上翻转的机制。这是膜生物学中一个重要的尚未解决的问题。发现翻转的分子基础对于理解生物膜的磷脂双分子层是如何传播的,以及各种糖脂的拓扑复杂合成是如何执行的至关重要。后一种过程是组装生物学上重要的细胞表面分子所必需的,如真核生物中n-糖基化和糖基磷脂酰肌醇(GPI)锚定的蛋白质,以及革兰氏阴性细菌中o抗原修饰的脂多糖。(Glyco)磷脂翻转在无蛋白脂质体中不会以可观的速率发生,但在内质网中通过蛋白质依赖、代谢能量独立、双向、促进的扩散过程迅速发生。我们假设特定的蛋白质,生物膜翻转酶,促进了内质网中极性脂质的跨双层扩散,包括甘油磷脂和基于异戊二烯的糖脂,这是本提案的重点。内质网中脂质翻转的特征排除了ABC转运蛋白的参与,而ABC转运蛋白已被确定为其他膜环境中潜在的脂质易位子。目前还没有发现生物源性膜翻转酶可以翻转甘油磷脂和异戊二烯类p糖,但令人信服的遗传证据表明,一种膜蛋白Rft1p在蛋白质n -糖基化的内质网定位途径中,作为一种翻转酶,可以翻转基于焦磷酸醇的糖脂。我们提出了两个特定的目标:表征和鉴定酵母和大鼠肝脏内质网中的甘油磷脂翻转酶,并从生化角度测试酵母Rft1p在翻转乙醇- pp基糖脂中的作用。这些研究将利用我们开发的程序,用于从ER的洗涤剂提取物中产生的蛋白脂质体的功能重建和脂质翻转测定。我们预计,我们的结果将定义一类新的膜蛋白,目前还没有明确的原型存在,并开始解决我们的最终目标,即获得生物膜中脂质翻转机制的分子定义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANANT K MENON其他文献

ANANT K MENON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANANT K MENON', 18)}}的其他基金

Scramblases for protein glycosylation
用于蛋白质糖基化的 Scramblases
  • 批准号:
    10420706
  • 财政年份:
    2022
  • 资助金额:
    $ 30.27万
  • 项目类别:
Molecular basis of congenital disorder of glycosylation type 1N
1N型先天性糖基化障碍的分子基础
  • 批准号:
    10700974
  • 财政年份:
    2022
  • 资助金额:
    $ 30.27万
  • 项目类别:
Molecular basis of congenital disorder of glycosylation type 1N
1N型先天性糖基化障碍的分子基础
  • 批准号:
    10510784
  • 财政年份:
    2022
  • 资助金额:
    $ 30.27万
  • 项目类别:
Scramblases for protein glycosylation
用于蛋白质糖基化的 Scramblases
  • 批准号:
    10600063
  • 财政年份:
    2022
  • 资助金额:
    $ 30.27万
  • 项目类别:
Rhodopsin-mediated phospholipid flipping
视紫红质介导的磷脂翻转
  • 批准号:
    8786659
  • 财政年份:
    2014
  • 资助金额:
    $ 30.27万
  • 项目类别:
Rhodopsin-mediated phospholipid flipping
视紫质介导的磷脂翻转
  • 批准号:
    8895952
  • 财政年份:
    2014
  • 资助金额:
    $ 30.27万
  • 项目类别:
Structural Analysis of the GPI Transamidase Complex
GPI 转酰胺酶复合物的结构分析
  • 批准号:
    8267601
  • 财政年份:
    2011
  • 资助金额:
    $ 30.27万
  • 项目类别:
Structural Analysis of the GPI Transamidase Complex
GPI 转酰胺酶复合物的结构分析
  • 批准号:
    8196655
  • 财政年份:
    2011
  • 资助金额:
    $ 30.27万
  • 项目类别:
Biosynthesis of Membrane Protein Glycolipid Anchors
膜蛋白糖脂锚的生物合成
  • 批准号:
    7938503
  • 财政年份:
    2009
  • 资助金额:
    $ 30.27万
  • 项目类别:
Phospholipid Flip-flop in Biogenic Membranes
生物膜中的磷脂触发器
  • 批准号:
    7080488
  • 财政年份:
    2005
  • 资助金额:
    $ 30.27万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 30.27万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 30.27万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.27万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.27万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 30.27万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.27万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 30.27万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 30.27万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 30.27万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.27万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了